TY - JOUR
T1 - Non-transdermal microneedles for advanced drug delivery
AU - Lee, Kang Ju
AU - Goudie, Marcus J.
AU - Tebon, Peyton
AU - Sun, Wujin
AU - Luo, Zhimin
AU - Lee, Junmin
AU - Zhang, Shiming
AU - Fetah, Kirsten
AU - Kim, Han Jun
AU - Xue, Yumeng
AU - Darabi, Mohammad Ali
AU - Ahadian, Samad
AU - Sarikhani, Einollah
AU - Ryu, Won Hyoung
AU - Gu, Zhen
AU - Weiss, Paul S.
AU - Dokmeci, Mehmet R.
AU - Ashammakhi, Nureddin
AU - Khademhosseini, Ali
N1 - Funding Information:
The authors have no competing interests. The authors also acknowledge funding from the National Institutes of Health ( EB021857 , AR066193 , AR057837, CA214411 , HL137193 , EB024403 , EB023052 , EB022403 and R01EB021857 ).
Publisher Copyright:
© 2019
PY - 2020/1
Y1 - 2020/1
N2 - Microneedles (MNs) have been used to deliver drugs for over two decades. These platforms have been proven to increase transdermal drug delivery efficiency dramatically by penetrating restrictive tissue barriers in a minimally invasive manner. While much of the early development of MNs focused on transdermal drug delivery, this technology can be applied to a variety of other non-transdermal biomedical applications. Several variations, such as multi-layer or hollow MNs, have been developed to cater to the needs of specific applications. The heterogeneity in the design of MNs has demanded similar variety in their fabrication methods; the most common methods include micromolding and drawing lithography. Numerous materials have been explored for MN fabrication which range from biocompatible ceramics and metals to natural and synthetic biodegradable polymers. Recent advances in MN engineering have diversified MNs to include unique shapes, materials, and mechanical properties that can be tailored for organ-specific applications. In this review, we discuss the design and creation of modern MNs that aim to surpass the biological barriers of non-transdermal drug delivery in ocular, vascular, oral, and mucosal tissue.
AB - Microneedles (MNs) have been used to deliver drugs for over two decades. These platforms have been proven to increase transdermal drug delivery efficiency dramatically by penetrating restrictive tissue barriers in a minimally invasive manner. While much of the early development of MNs focused on transdermal drug delivery, this technology can be applied to a variety of other non-transdermal biomedical applications. Several variations, such as multi-layer or hollow MNs, have been developed to cater to the needs of specific applications. The heterogeneity in the design of MNs has demanded similar variety in their fabrication methods; the most common methods include micromolding and drawing lithography. Numerous materials have been explored for MN fabrication which range from biocompatible ceramics and metals to natural and synthetic biodegradable polymers. Recent advances in MN engineering have diversified MNs to include unique shapes, materials, and mechanical properties that can be tailored for organ-specific applications. In this review, we discuss the design and creation of modern MNs that aim to surpass the biological barriers of non-transdermal drug delivery in ocular, vascular, oral, and mucosal tissue.
UR - http://www.scopus.com/inward/record.url?scp=85076840361&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076840361&partnerID=8YFLogxK
U2 - 10.1016/j.addr.2019.11.010
DO - 10.1016/j.addr.2019.11.010
M3 - Review article
C2 - 31837356
AN - SCOPUS:85076840361
SN - 0169-409X
VL - 165-166
SP - 41
EP - 59
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
ER -